EXHIBIT 99  Cautionary Statement Under Private Securities Litigation Reform Act
            Of 1995 - "Safe Harbor" For Forward-Looking Disclosures

Certain forward-looking statements are included in this Form 10-Q and may be
made by Company spokespersons based on current expectations of management.  All
forward-looking statements made by the Company are subject to risks and
uncertainties.  Certain factors, including but not limited to those listed
below, may cause actual results to differ materially from current expectations
and historical results.

- -  Economic factors over which the Company has no control, including changes in
   inflation, interest rates, foreign currency exchange rates and the Euro
   conversion.

- -  Competitive factors including generic competition as patents on key products,
   such as Prozac, expire; pricing pressures, both in the U.S. and abroad,
   primarily from managed care groups and government agencies; and technological
   advances and patents obtained by competitors.

- -  Governmental factors including laws, regulations, and judicial decisions at
   the state and federal level related to Medicare, Medicaid and healthcare
   reform; and laws and regulations affecting international pricing and
   pharmaceutical reimbursement.

- -  The difficulties and uncertainties inherent in new product development.  New
   product candidates that appear promising in development may fail to reach the
   market or may not be as commercially successful as anticipated because of
   efficacy or safety concerns, inability to obtain necessary regulatory
   approvals, limitations on approved indications, difficulty or excessive costs
   to manufacture, or infringement of the patents or intellectual property
   rights of others.

- -  Delays and uncertainties in the FDA approval process and the approval
   processes in other countries, resulting in lost market opportunity.
 
- -  Unexpected safety or efficacy concerns arising with respect to marketed
   products, whether or not scientifically justified, leading to product
   recalls, withdrawals or declining sales.

- -  Legal factors including unanticipated litigation of product liability claims;
   antitrust litigation; environmental matters; and patent disputes with
   competitors which could preclude commercialization of products or negatively
   affect the profitability of existing products.

- -  Future difficulties obtaining or the inability to obtain existing levels of
   product liability insurance.

- -  Changes in tax laws, including the amendment to the Section 936 income tax
   credit, and future changes in tax laws related to the remittance of foreign
   earnings or investments in foreign countries with favorable tax rates.

- -  Changes in accounting standards promulgated by the Financial Accounting
   Standards Board, the Securities and Exchange Commission, and the American
   Institute of Certified Public Accountants which are adverse to the Company.

- -  Factors such as changes in business strategies and the impact of
   restructurings, impairments in asset carrying values and business
   combinations.
       
- -  Difficulties in modification or replacement of existing computer systems,
   software, and/or non-IT systems in order to render the Company's various
   systems ready for the Year 2000, including the difficulties encountered by
   third party vendors, suppliers, and/or customers in their failure to render
   their systems ready for the Year 2000.